[{"NetIncomeLoss_1_Q1_USD":33395000.0,"InterestPaidNet_2_Q1_USD":4237000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-83142000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":53200000.0,"IncomeTaxesPaid_2_Q1_USD":6034000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q1_USD":-8138000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":20510000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":700000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":-4890000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":11914000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":3326000.0,"DividendsCommonStockCash_1_Q1_USD":12336000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":10424000.0,"AssetsCurrent_0_Q1_USD":541893000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1489000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":5987000.0,"LongTermDebtCurrent_0_Q1_USD":12500000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":72598000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q1_USD":2143000.0,"ContractWithCustomerLiability_0_Q1_USD":13400000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":66468000.0,"PaymentsToAcquireAvailableForSaleSecurities_2_Q1_USD":26239000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1500000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":13728000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":11369000.0,"CommonStockSharesIssued_0_Q1_shares":38601131.0,"Assets_0_Q1_USD":2053096000.0,"ShareBasedCompensation_2_Q1_USD":12953000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":70018000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":56.71,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_0_Q1_USD":50698000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":37737000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":13004000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.32,"EarningsPerShareBasic_1_Q1_USD":0.87,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q1_USD":29039000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":40025000.0,"AssetsFairValueDisclosure_0_Q1_USD":117986000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-5451000.0,"AccountsReceivableNetCurrent_0_Q1_USD":122635000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":5944000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_0_Q1_USD":58326000.0,"CommonStockValue_0_Q1_USD":386000.0,"InvestmentIncomeNet_1_Q1_USD":114000.0,"RepaymentsOfLinesOfCredit_2_Q1_USD":33125000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q1_USD":-6918000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_0_Q1_USD":56447000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q1_USD":-1632000.0,"DepreciationDepletionAndAmortization_2_Q1_USD":21088000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.151,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q1_USD":-11480000.0,"OperatingLeaseLiability_0_Q1_USD":75389000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":448679000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":65694000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":169404000.0,"OtherAssetsNoncurrent_0_Q1_USD":10281000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":15575000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_2_Q1_USD":-910000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":47452000.0,"IncreaseDecreaseInInventories_2_Q1_USD":1968000.0,"OtherAssetsCurrent_0_Q1_USD":25865000.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":117986000.0,"DerivativeFairValueOfDerivativeLiability_0_Q1_USD":14523000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q1_USD":-34933000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":16041000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":33374000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":15477000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":9529000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q1_USD":311139000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":39339000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":12667000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q1_USD":66009000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":52808000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":38536000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":5788000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":12280000.0,"LiabilitiesCurrent_0_Q1_USD":105424000.0,"AccountsPayableCurrent_0_Q1_USD":27190000.0,"NonoperatingIncomeExpense_1_Q1_USD":-9753000.0,"InterestExpense_1_Q1_USD":4416000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q1_USD":-159000.0,"ProceedsFromStockOptionsExercised_2_Q1_USD":15418000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q1_USD":-452000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":2157000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":507591000.0,"NetIncomeLoss_2_Q1_USD":33395000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":191677000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q1_USD":-4890000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":199000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":101374000.0,"OperatingLeasePayments_1_Q1_USD":3230000.0,"Goodwill_0_Q1_USD":731636000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":507591000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":116816.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":169404000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":33374000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0438,"PaymentsOfDividendsCommonStock_2_Q1_USD":12336000.0,"GrossProfit_1_Q1_USD":137731000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1463000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":90866000.0,"ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_1_Q1_USD":3300000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":14057000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":204199000.0,"OperatingIncomeLoss_1_Q1_USD":49092000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q1_USD":-1383000.0,"InventoryNet_0_Q1_USD":106003000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":16900000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":13285000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":267.79,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2053096000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":21805000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":13333000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":367097000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":9695000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":44908000.0,"OperatingExpenses_1_Q1_USD":88639000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":706000.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_1_Q1_USD":-1486000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":29981000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":175420000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":4800000.0,"EarningsPerShareDiluted_1_Q1_USD":0.83,"CommonStockSharesOutstanding_0_Q1_shares":38601131.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q1_USD":21000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q1_USD":22779000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q1_USD":195000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":1073362000.0,"VariableLeaseCost_1_Q1_USD":700000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q1_USD":286000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":1429000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q1_USD":10938000.0,"StockholdersEquity_0_Q1_USD":1439285000.0,"FinitelivedIntangibleAssetsAcquired1_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_0_Q1_USD":53892000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":9527000.0,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20201109"}]